139 related articles for article (PubMed ID: 33324384)
1. Exopolysaccharide Producing
Sabater C; Molinero-García N; Castro-Bravo N; Diez-Echave P; Hidalgo-García L; Delgado S; Sánchez B; Gálvez J; Margolles A; Ruas-Madiedo P
Front Microbiol; 2020; 11():601233. PubMed ID: 33324384
[TBL] [Abstract][Full Text] [Related]
2. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation.
Yan S; Yang B; Zhao J; Zhao J; Stanton C; Ross RP; Zhang H; Chen W
Food Funct; 2019 Mar; 10(3):1595-1608. PubMed ID: 30806428
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model.
Hidalgo-Cantabrana C; Algieri F; Rodriguez-Nogales A; Vezza T; Martínez-Camblor P; Margolles A; Ruas-Madiedo P; Gálvez J
Front Microbiol; 2016; 7():868. PubMed ID: 27375589
[TBL] [Abstract][Full Text] [Related]
4. Gene Replacement and Fluorescent Labeling to Study the Functional Role of Exopolysaccharides in
Castro-Bravo N; Hidalgo-Cantabrana C; Rodriguez-Carvajal MA; Ruas-Madiedo P; Margolles A
Front Microbiol; 2017; 8():1405. PubMed ID: 28790996
[TBL] [Abstract][Full Text] [Related]
5. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
[TBL] [Abstract][Full Text] [Related]
6. Insights into the ropy phenotype of the exopolysaccharide-producing strain Bifidobacterium animalis subsp. lactis A1dOxR.
Hidalgo-Cantabrana C; Sánchez B; Moine D; Berger B; de Los Reyes-Gavilán CG; Gueimonde M; Margolles A; Ruas-Madiedo P
Appl Environ Microbiol; 2013 Jun; 79(12):3870-4. PubMed ID: 23584772
[TBL] [Abstract][Full Text] [Related]
7. Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue.
Hidalgo-Cantabrana C; Nikolic M; López P; Suárez A; Miljkovic M; Kojic M; Margolles A; Golic N; Ruas-Madiedo P
Anaerobe; 2014 Apr; 26():24-30. PubMed ID: 24445155
[TBL] [Abstract][Full Text] [Related]
8. Exopolysaccharides synthesized by Bifidobacterium animalis subsp. lactis interact with TLR4 in intestinal epithelial cells.
Castro-Bravo N; Margolles A; Wells JM; Ruas-Madiedo P
Anaerobe; 2019 Apr; 56():98-101. PubMed ID: 30794874
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics.
Nikolic M; López P; Strahinic I; Suárez A; Kojic M; Fernández-García M; Topisirovic L; Golic N; Ruas-Madiedo P
Int J Food Microbiol; 2012 Aug; 158(2):155-62. PubMed ID: 22858135
[TBL] [Abstract][Full Text] [Related]
10. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Immunomodulation and Shifts on the Gut Microbiota of BALB/c Mice Promoted by Two
Nogacka AM; Oddi S; Salazar N; Reinheimer JA; Gueimonde M; Vinderola G; de Los Reyes-Gavilán CG
Biomed Res Int; 2019; 2019():2323540. PubMed ID: 31119156
[No Abstract] [Full Text] [Related]
12. Technological characterization and survival of the exopolysaccharide-producing strain Lactobacillus delbrueckii subsp. lactis 193 and its bile-resistant derivative 193+ in simulated gastric and intestinal juices.
Burns P; Vinderola G; Reinheimer J; Cuesta I; de Los Reyes-Gavilán CG; Ruas-Madiedo P
J Dairy Res; 2011 Aug; 78(3):357-64. PubMed ID: 21774862
[TBL] [Abstract][Full Text] [Related]
13. Characterization of exopolysaccharide-producing lactic acid bacteria from Taiwanese ropy fermented milk and their application in low-fat fermented milk.
Ng KS; Chang YC; Chen YP; Lo YH; Wang SY; Chen MJ
Anim Biosci; 2022 Feb; 35(2):281-289. PubMed ID: 34530518
[TBL] [Abstract][Full Text] [Related]
14. Effects of
Zhou L; Yin X; Fang B; He J; Zhan J; Zhang X; Wang R
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543544
[TBL] [Abstract][Full Text] [Related]
15. Exopolysaccharides from a Scandinavian fermented milk viili increase butyric acid and
Yamane T; Handa S; Imai M; Harada N; Sakamoto T; Ishida T; Nakagaki T; Nakano Y
Food Chem (Oxf); 2021 Dec; 3():100042. PubMed ID: 35415651
[TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.
Veiga P; Gallini CA; Beal C; Michaud M; Delaney ML; DuBois A; Khlebnikov A; van Hylckama Vlieg JE; Punit S; Glickman JN; Onderdonk A; Glimcher LH; Garrett WS
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18132-7. PubMed ID: 20921388
[TBL] [Abstract][Full Text] [Related]
17. The beneficial effect of exopolysaccharides from Bifidobacterium bifidum WBIN03 on microbial diversity in mouse intestine.
Li S; Chen T; Xu F; Dong S; Xu H; Xiong Y; Wei H
J Sci Food Agric; 2014 Jan; 94(2):256-64. PubMed ID: 23716082
[TBL] [Abstract][Full Text] [Related]
18. Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro.
Liu G; Chen H; Chen J; Wang X; Gu Q; Yin Y
Appl Microbiol Biotechnol; 2019 Feb; 103(4):1693-1702. PubMed ID: 30569218
[TBL] [Abstract][Full Text] [Related]
19. Production of exopolysaccharides by Lactobacillus and Bifidobacterium strains of human origin, and metabolic activity of the producing bacteria in milk.
Salazar N; Prieto A; Leal JA; Mayo B; Bada-Gancedo JC; de los Reyes-Gavilán CG; Ruas-Madiedo P
J Dairy Sci; 2009 Sep; 92(9):4158-68. PubMed ID: 19700676
[TBL] [Abstract][Full Text] [Related]
20. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection.
Fanning S; Hall LJ; Cronin M; Zomer A; MacSharry J; Goulding D; Motherway MO; Shanahan F; Nally K; Dougan G; van Sinderen D
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2108-13. PubMed ID: 22308390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
